ConductScience.org, home

Trial · NCT03001076

Outcomes14

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYPercent Change From Baseline to Week 12 in Low-Density Lipoprotein Cholesterol (LDL-C)Week 12Full Analysis Set: all randomized participantspercent changeLEAST_SQUARES_MEAN
SECONDARYPercent Change From Baseline to Week 12 in Non-high-density Lipoprotein Cholesterol (Non-HDL-C)Week 12Full Analysis Setpercent changeLEAST_SQUARES_MEAN
SECONDARYPercent Change From Baseline to Week 12 in Total Cholesterol (TC)Week 12Full Analysis SetPercent changeLEAST_SQUARES_MEAN
SECONDARYPercent Change From Baseline to Week 12 in Apolipoprotein B (apoB)Week 12Full Analysis SetPercent changeLEAST_SQUARES_MEAN
SECONDARYPercent Change From Baseline to Week 12 in High-sensitivity C-reactive Protein (hsCRP)Week 12Full Analysis Set. Only participants with available data were analyzed.Percent changeMEDIAN
SECONDARYPercent Change From Baseline to Week 12 in Triglycerides (TGs)Week 12Full Analysis Set. Only participants with available data were analyzed.Percent changeLEAST_SQUARES_MEAN
SECONDARYPercent Change From Baseline to Week 12 in High-density Lipoprotein Cholesterol (HDL-C)Week 12Full Analysis Set. Only participants with available data were analyzed.percent changeLEAST_SQUARES_MEAN
SECONDARYNumber of Participants With Treatment-emergent Adverse Events (TEAEs)Up to approximately 16 weeks
Safety Analysis Set: all randomized participants who received at least 1 dose of study medication. Participants were included in the treatment group that they actually received, regardless of their randomized treatment.
ParticipantsNUMBER
OTHER_PRE_SPECIFIEDPercent Change From Baseline to Weeks 4 and 8 in LDL-CWeek 4 and Week 8Full Analysis Set. Only participants with available data were analyzed.Percent changeLEAST_SQUARES_MEAN
OTHER_PRE_SPECIFIEDPercent Change From Baseline to Weeks 4 and 8 in Non-HDL-CWeek 4 and Week 8Full Analysis Set. Only participants with available data were analyzed.Percent changeLEAST_SQUARES_MEAN
OTHER_PRE_SPECIFIEDPercent Change From Baseline to Weeks 4 and 8 in TCWeek 4 and Week 8Full Analysis Set. Only participants with available data were analyzed.Percent changeLEAST_SQUARES_MEAN
OTHER_PRE_SPECIFIEDPercent Change From Baseline to Weeks 4 and 8 in TGsWeek 4 and Week 8Full Analysis Set. Only participants with available data were analyzed.Percent changeLEAST_SQUARES_MEAN
OTHER_PRE_SPECIFIEDPercent Change From Baseline to Weeks 4 and 8 in HDL-CWeek 4 and Week 8Full Analysis Set. Only participants with available data were analyzed.Percent changeLEAST_SQUARES_MEAN
OTHER_PRE_SPECIFIEDAbsolute Change From Baseline to Weeks 4, 8, and 12 in LDL-CWeek 4, Week 8 and Week 12Full Analysis Set. Only participants with available data were analyzed.milligrams per deciliter (mg/dL)GEOMETRIC_MEAN

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03001076/outcomes